cell therapy
The majority of experts agreed that the FDA couldn't make a regulatory decision based on the data the firm has submitted on the autologous stem cell therapy.
Abeona Therapeutics Submits BLA for Recessive Dystrophic Epidermolysis Bullosa Cell Therapy
The company submitted safety and efficacy data on the autologous, engineered cell therapy, EB-101, from the pivotal Phase III VIITAL trial.
Nektar, Cellular Biomedicine Partner to Develop Combo TIL Therapy in NSCLC
Cellular Biomedicine hopes to boost response to its tumor infiltrating lymphocyte therapy in lung cancer by combining it with Nektar's interleukin-15 agonist and anti-PD1 therapy.
Cedars-Sinai Sets Up $25M Single Cell Precision Medicine Center
The center will be established with a $25 million philanthropic gift from Alfred E. Mann Charities and will be named in honor of the late inventor.
ImmPact Bio Treats First Lymphoma Patient in Phase I/II CAR T-Cell Therapy Trial
The firm is studying the safety and efficacy of IMPT-314, its CD19/CD20-directed autologous cell therapy, for relapsed or refractory B-cell lymphoma.